IL109540A0 - Synthetic peptides and their use in tumor diagnosis and therapy - Google Patents

Synthetic peptides and their use in tumor diagnosis and therapy

Info

Publication number
IL109540A0
IL109540A0 IL10954094A IL10954094A IL109540A0 IL 109540 A0 IL109540 A0 IL 109540A0 IL 10954094 A IL10954094 A IL 10954094A IL 10954094 A IL10954094 A IL 10954094A IL 109540 A0 IL109540 A0 IL 109540A0
Authority
IL
Israel
Prior art keywords
therapy
synthetic peptides
tumor diagnosis
tumor
diagnosis
Prior art date
Application number
IL10954094A
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL10954094A priority Critical patent/IL109540A0/en
Publication of IL109540A0 publication Critical patent/IL109540A0/en
Priority to PCT/US1995/004912 priority patent/WO1995029698A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/55—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10954094A 1994-05-03 1994-05-03 Synthetic peptides and their use in tumor diagnosis and therapy IL109540A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL10954094A IL109540A0 (en) 1994-05-03 1994-05-03 Synthetic peptides and their use in tumor diagnosis and therapy
PCT/US1995/004912 WO1995029698A1 (en) 1994-05-03 1995-05-03 Tumor-associated antigen peptides and their use in tumor diagnosis and therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10954094A IL109540A0 (en) 1994-05-03 1994-05-03 Synthetic peptides and their use in tumor diagnosis and therapy

Publications (1)

Publication Number Publication Date
IL109540A0 true IL109540A0 (en) 1994-08-26

Family

ID=11066096

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10954094A IL109540A0 (en) 1994-05-03 1994-05-03 Synthetic peptides and their use in tumor diagnosis and therapy

Country Status (2)

Country Link
IL (1) IL109540A0 (en)
WO (1) WO1995029698A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5651993A (en) 1992-11-18 1997-07-29 Yale University Specific immune system modulation
EP1176986B1 (en) 1999-04-20 2018-07-04 Yale University Differentiation of monocytes into functional dendritic cells
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells

Also Published As

Publication number Publication date
WO1995029698A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
EP0623020A4 (en) Pyropheophorbides and their use in photodynamic therapy.
ZA956005B (en) Iron-containing nanoparticles their production and their use for diagnostic and therapeutic purposes
ZA9710339B (en) Xanthines and their therapeutic use
EP1173191A4 (en) Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
HU9502117D0 (en) Potentiation of temezolomide in human tumor cells
AU2603895A (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
IL109540A0 (en) Synthetic peptides and their use in tumor diagnosis and therapy
IL112993A0 (en) Recombinant niruses, their preparation and their use in gene therapy
IL116658A0 (en) Peptides their preparation and use
GB9514816D0 (en) Substances and their medical use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
GB9421223D0 (en) Tissue imaging in gene therapy
GB9614416D0 (en) Antigen for use in cancer therapy and diagnosis
GB9621093D0 (en) Antigen for use in cancer therapy and diagnosis
GB9013872D0 (en) Use of protein a and polypeptide components thereof in the treatment of tumours
GB9616504D0 (en) Therapeutic product and its use
AU5279996A (en) Antibodies and their use in cancer therapy and diagnosis
GB9416321D0 (en) Peptides and antibodies and their use in treatment of carcinomas
GB9621314D0 (en) Substances and their therapeutic use
GB9609521D0 (en) Substances and their therapeutic use